Association Between SARS-CoV-2 Viral Load and COVID-19 Vaccination in 4 Phase 3 Trials

被引:3
作者
Janes, Holly [1 ]
Fisher, Leigh H. [1 ]
Kee, Jia Jin [1 ]
Parameswaran, Lalitha [2 ]
Goepfert, Paul A. [3 ]
Falsey, Ann R. [4 ]
Ludwig, James [1 ]
Magaret, Craig A. [1 ]
Gilbert, Peter B. [1 ]
Kublin, James G. [1 ]
Rouphael, Nadine [5 ]
Sobieszczyk, Magdalena E. [6 ]
El Sahly, Hana M. [7 ]
Baden, Lindsey R. [8 ]
Grinsztejn, Beatriz [9 ]
Walsh, Stephen R. [8 ]
Gray, Glenda E. [10 ]
Kotloff, Karen L. [11 ]
Gay, Cynthia L. [12 ]
Greninger, Alexander L. [13 ]
Tapia, Milagritos D. [11 ]
Hammershaimb, E. Adrianne [11 ]
Priddy, Frances H. [14 ]
Green, Justin A. [15 ]
Struyf, Frank [16 ]
Dunkle, Lisa [17 ]
Neuzil, Kathleen M. [18 ]
Corey, Lawrence [1 ]
Huang, Yunda [1 ]
机构
[1] Fred Hutchinson Canc Ctr, Vaccine & Infect Dis Div, 1100 Fairview Ave N,Mail Stop M2-C200, Seattle, WA 98109 USA
[2] NYU, Langone Vaccine Ctr, Grossman Sch Med, New York, NY USA
[3] Univ Alabama Birmingham, Heersink Sch Med, Birmingham, AL USA
[4] Univ Rochester, Infect Dis Div, Rochester, NY USA
[5] Emory Univ, Hope Clin, Atlanta, GA USA
[6] Columbia Univ, Irving Med Ctr, Dept Med, New York, NY USA
[7] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX USA
[8] Brigham & Womens Hosp, Div Infect Dis, Boston, MA USA
[9] Oswaldo Cruz Fdn Fiocruz, Evandro Chagas Natl Inst Infect Dis, Rio De Janeiro, Brazil
[10] South African Med Res Council, Cape Town, South Africa
[11] Univ Maryland, Ctr Vaccine Dev & Global Hlth, Dept Pediat, Sch Med, Baltimore, MD USA
[12] Univ N Carolina, Sch Med, Div Infect Dis, Chapel Hill, NC USA
[13] Univ Washington, Med Ctr, Dept Med Lab Med & Pathol, Seattle, WA USA
[14] Moderna Inc, Cambridge, MA USA
[15] AstraZeneca, Vaccines & Immune Therapies, BioPharmaceut Res & Dev, Cambridge, England
[16] Janssen Res & Dev, Beerse, Belgium
[17] Novavax Inc, Gaithersburg, MD USA
[18] Univ Maryland, Sch Med, Ctr Vaccine Dev & Global Hlth, Baltimore, MD USA
关键词
COVID-19; vaccine; SARS-CoV-2 viral load; transmission; randomized trial; infectiousness;
D O I
10.1093/infdis/jiae400
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Coronavirus disease 2019 (COVID-19) vaccines reduce severe disease and mortality and may lessen transmission, measured by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral load (VL). Evaluating vaccine associations in VL at COVID-19 diagnosis in 4 phase 3 randomized, placebo-controlled vaccine trials, July 2020 to July 2021, VL reductions were 2.78 log10 copies/mL (95% confidence interval [CI], 1.38-4.18; n = 60 placebo, 11 vaccine) and 2.12 log10 copies/mL (95% CI, 1.44-2.80; n = 594 placebo, 36 vaccine) for NVX-CoV2373 and mRNA-1273, respectively. Associations were not significant for AZD1222 (0.59 log10 copies/mL; 95% CI, -.19 to 1.36; n = 90 placebo, 78 vaccine) or Ad26.COV2.S (0.23 log10 copies/mL; 95% CI, -.01 to .47; n = 916 placebo, 424 vaccine). Thus, vaccines potentially decreased transmission when ancestral SARS-CoV-2 predominated.Clinical Trials Registration. NCT04470427, NCT04505722, NCT04516746, NCT04611802. Analyses of the initial phase 3 US government-funded COVID-19 vaccine trials reveals that first-generation COVID-19 vaccines may have decreased short-term transmission while the ancestral strain predominated.
引用
收藏
页码:1384 / 1389
页数:6
相关论文
共 50 条
[21]   Trends in occurrence of takotsubo syndrome and association with SARS-CoV-2 infection and COVID-19 vaccination [J].
Rosh, Bar ;
Naoum, Ibrahim ;
Stein, Nili ;
Jaffe, Ronen ;
Saliba, Walid .
JOURNAL OF CARDIOVASCULAR MEDICINE, 2023, 24 (11) :815-821
[22]   SARS-CoV-2 Vaccination in Patients with Cancer and COVID-19 in Mexico [J].
Barrientos-Flores, Corazon ;
Vilar-Compte, Diana ;
Martinez-Rivera, Nancy ;
Villasenor-Echavarri, Rodrigo ;
Martin-Onraet, Alexandra .
VACCINES, 2024, 12 (10)
[23]   COVID-19, SARS-CoV-2 Vaccination, and Human Herpesviruses Infections [J].
Maple, Peter A. C. .
VACCINES, 2023, 11 (02)
[24]   COVID-19 in immunocompromised children: comparison of SARS-CoV-2 viral load dynamics between the first and third waves [J].
Matías Moragas ;
Marcelo D. Golemba ;
María F. Fernández ;
Marcela Palladino ;
Sandra Gómez ;
Daniela Borgnia ;
Martín Ruhle ;
Ana Arias ;
Silvina Ruvinsky ;
Rosa Bologna ;
Andrea Mangano .
Brazilian Journal of Microbiology, 2023, 54 :1859-1864
[25]   COVID-19 in immunocompromised children: comparison of SARS-CoV-2 viral load dynamics between the first and third waves [J].
Moragas, Matias ;
Golemba, Marcelo D. ;
Fernandez, Maria F. ;
Palladino, Marcela ;
Gomez, Sandra ;
Borgnia, Daniela ;
Ruhle, Martin ;
Arias, Ana ;
Ruvinsky, Silvina ;
Bologna, Rosa ;
Mangano, Andrea .
BRAZILIAN JOURNAL OF MICROBIOLOGY, 2023, 54 (03) :1859-1864
[26]   Effect of Previous COVID-19 Vaccination on Humoral Immunity 3 Months after SARS-CoV-2 Omicron Infection and Booster Effect of a Fourth COVID-19 Vaccination 2 Months after SARS-CoV-2 Omicron Infection [J].
Kim, Jinsoo ;
Seo, Hyeonji ;
Kim, Han-Wool ;
Kim, Dongbum ;
Kwon, Hyung-Joo ;
Kim, Yong-Kyun .
VIRUSES-BASEL, 2022, 14 (11)
[27]   Coagulation factor inhibitors in COVID-19: From SARS-CoV-2 vaccination to infection [J].
Jacobs, Jeremy W. ;
Adkins, Brian D. ;
Walker, Shannon C. ;
Booth, Garrett S. ;
Wheeler, Allison P. .
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2022, 6 (03)
[28]   The Impact of Vaccination Against SARS-CoV-2 Virus on the Outcome of COVID-19 Disease [J].
AlKhafaji, Dania M. ;
Argan, Reem J. Al ;
AlBahrani, Salma ;
Alwaheed, Abrar J. ;
Alqatari, Safi G. ;
Al Elq, Abdulmohsen H. ;
Albaker, Waleed ;
Alwazzeh, Marwan ;
AlSulaiman, Amal S. ;
AlSulaiman, Reem S. ;
Almadan, Hussain M. ;
Alhammad, Ali A. ;
Almajid, Ali N. ;
Hakami, Fatimah H. ;
Alanazi, Wafa .
INFECTION AND DRUG RESISTANCE, 2022, 15 :3477-3489
[29]   Antibody Responses to Natural SARS-CoV-2 Infection or after COVID-19 Vaccination [J].
Altawalah, Haya .
VACCINES, 2021, 9 (08)
[30]   Oral Lesions in Pediatric Subjects: SARS-CoV-2 Infection and COVID-19 Vaccination [J].
Di Spirito, Federica ;
Caggiano, Mario ;
Di Palo, Maria Pia ;
Contaldo, Maria ;
D'Ambrosio, Francesco ;
Martina, Stefano ;
Amato, Alessandra .
APPLIED SCIENCES-BASEL, 2022, 12 (18)